48,830
edits
(→Hepatic metastasis: more) |
(→IHC) |
||
Line 540: | Line 540: | ||
HCC vs. ICC:<ref name=pmid16627262>{{cite journal |author=Lei JY, Bourne PA, diSant'Agnese PA, Huang J |title=Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver |journal=Am. J. Clin. Pathol. |volume=125 |issue=4 |pages=519–25 |year=2006 |month=April |pmid=16627262 |doi=10.1309/59TN-EFAL-UL5W-J94M |url=}}</ref> | HCC vs. ICC:<ref name=pmid16627262>{{cite journal |author=Lei JY, Bourne PA, diSant'Agnese PA, Huang J |title=Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver |journal=Am. J. Clin. Pathol. |volume=125 |issue=4 |pages=519–25 |year=2006 |month=April |pmid=16627262 |doi=10.1309/59TN-EFAL-UL5W-J94M |url=}}</ref> | ||
*TTF-1: ~90-100% +ve (cytoplasmic) in HCC vs. ~10% in cholangiocarcinoma. | *TTF-1: ~90-100% +ve (cytoplasmic) in HCC vs. ~10% in cholangiocarcinoma. | ||
===Sign out=== | |||
<pre> | |||
MASS, PANCREAS, CORE BIOPSY: | |||
- ADENOCARCINOMA, MODERATELY DIFFERENTIATED. | |||
</pre> | |||
Note: | |||
*On biopsy, the it isn't possible to cleanly separate from [[pancreatic adenocarcinoma]]. | |||
====Micro==== | |||
The sections show cores of pancreas. An atypical gland-forming lesion, in a fibrous | |||
background, is present. This lesion is separate from the benign pancreatic glands that are | |||
present. The atypical glands are unequally spaced. Moderate-to-marked cytologic atypia is | |||
present. Mitotic activity is not apparent. | |||
==Hepatic angiosarcoma== | ==Hepatic angiosarcoma== |
edits